Logo Right Banner
Loading images...
lineee seperator

Search

Search for an Article. Please enter Topic, Keywords or a Phrase

lineee seperator

HCN News & Notes

12,000 Children in Bay State Still lack in Insurance
Greenfield Center for Wellness Set to Open
Elms Names YWCA Director Elizabeth Dineen New Trustee
Baystate Mary Lane to Host Colon Health Program on March 20
lineee seperator
Loading images...
lineee seperator
Loading images...
Loading images...
Loading images...

Loading images...
Loading images...


Previous Issues

  • 2018
  • 2017
  • 2016
  • 2015
  • 2014
  • 2013
  • 2012
  • 2011
  • 2010
  • 2009
  • 2008
  • 2007
  • 2006
  • 2005
  • 2004
  • 2003
  • 2002

  • AMA Applauds FDA Approval of Implant to Fight Opioid Addiction


    WASHINGTON, D.C. — Dr. Patrice Harris, chair-elect of the American Medical Assoc., praised the U.S. Food and Drug Administration (FDA) for approving a new, implantable option to help treat patients with substance-use disorders.

    “With nearly 2.5 million Americans addicted to prescription opioids and heroin, patients will benefit from increased options for medication-assisted treatment,” she said. “Today’s approval by FDA, however, is only one of many steps we must take to rein in our spiraling opioid crisis. As physicians, we must avoid initiating opioids for new patients with chronic non-cancer pain unless the expected benefits are anticipated to outweigh the risks, we must limit the amount of opioids prescribed for post-operative care and acutely injured patients, and we must register for and use our state prescription-drug monitoring programs to assist in the care of patients when considering the use of controlled substances. There is no panacea to the opioid crisis.”

    © Copyright Health Care News
    All rights reserved throughout the World
    Any unauthorized duplication of this site is strictly prohibited and liable to prosecution.
    Site maintained and designed by INTERNET BUSINESS SOLUTIONS